ANDA 40525, held by Sun Pharm Industries. Phentermine Hydrochloride.
As of Nov 16, 2026, ANDA 40525 (Phentermine Hydrochloride), held by Sun Pharm Industries, was first approved by FDA on Oct 23, 2003, with 4 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Oct 23, 2003 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Phentermine Hydrochloride30MG · capsule;oral | Phentermine Hydrochloride | Discontinued |
| May 31, 2017 | Supplement 17Labeling · Standard review | Approved | None posted |
| Dec 6, 2012 | Supplement 11Labeling · Standard review | Approved | None posted |
| Dec 6, 2012 | Supplement 12Labeling · Standard review | Approved | None posted |
| Oct 23, 2003 | Original application | Approved | None posted |
| Oct 23, 2003 | Supplement 1 | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters